A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors

PHASE1RecruitingINTERVENTIONAL

Enrollment

380

Participants

Timeline

Start Date

July 15, 2025

Primary Completion Date

November 18, 2027

Study Completion Date

November 28, 2027

Conditions

Colorectal Neoplasms

Interventions

DRUG

JNJ-95437446

JNJ-95437446 will be administered.

Trial Locations (2)

RECRUITING

NEXT Oncology, Fairfax

RECRUITING

Florida Cancer Specialists, Sarasota

All Listed Sponsors

lead

Janssen Research & Development, LLC

INDUSTRY